Cargando…
Clinical whole‐exome sequencing results impact medical management
BACKGROUND: Clinical diagnostic whole‐exome sequencing (WES) is a powerful tool for patients with undiagnosed genetic disorders. To demonstrate the clinical utility, we surveyed healthcare providers (HCP) about changes in medical management and treatment, diagnostic testing, reproductive planning, a...
Autores principales: | Niguidula, Nancy, Alamillo, Christina, Shahmirzadi Mowlavi, Layla, Powis, Zöe, Cohen, Julie S., Farwell Hagman, Kelly D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305629/ https://www.ncbi.nlm.nih.gov/pubmed/30318729 http://dx.doi.org/10.1002/mgg3.484 |
Ejemplares similares
-
Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing
por: Shahmirzadi, Layla, et al.
Publicado: (2014) -
Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases
por: Farwell Hagman, Kelly D., et al.
Publicado: (2017) -
Correction: Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases
por: Farwell Hagman, Kelly D, et al.
Publicado: (2018) -
Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017) -
When moments matter: Finding answers with rapid exome sequencing
por: Powis, Zöe, et al.
Publicado: (2019)